Countries Consider Pandemic Pooling of Rights And Compulsory Licensing

Transparency of R&D Costs Also Requested

Mar 26 2020

• By Francesca Bruce

Listen to this article

Intellectual property rights are under the microscope as countries prepare to provide affordable and timely access to pandemic technologies.

Coronavirus — Countries Consider How To Make COVID-19 Technologies Accessible

In an important move in the fight against the pandemic, Costa Rica has requested that the World Health Organization head an initiative to pool intellectual property rights relating to coronavirus technologies. Meanwhile Chile and Ecuador have paved the way for compulsory licenses, and the demand for more transparency on the costs of R&D and public financing is growing.

Costa Rica’s president, Carlos Alarado Quesada, and health minister Daniel Salas Peraza have written to the World Health Organization asking...

More from Latin America

Brazil Issues Guidance On Regulatory Reliance & Equivalent Authorities
Oct 02 2024
• By Francesca Bruce
Brazilian regulator Anvisa is relying on the decisions of its foreign counterparts as a means of ensuring more quality medicines are made available in the country.
Anvisa To Access US FDA-Reviewed Data For More Robust Evaluations In Brazil
Oct 02 2024
• By Francesca Bruce
Brazil has also published its recent regulatory reliance regulations in English, a move designed to increase confidence in its decisions as it presses on with aligning its national practices with global best practices.
Colombia Signs Agreement With PAHO To Strengthen Regulatory Capacity
May 16 2024
• By Francesca Bruce
The deal comes at a time when Latin American countries are increasingly looking to improve the regulatory environment for pharmaceuticals and move towards greater convergence.
Mexico Launches ‘Regulatory Certainty Strategy’ For Biosimilars
Feb 13 2024
• By Francesca Bruce
Mexico is to establish a new regulatory framework that is in line with international standards to encourage domestic production of biosimilar medicines.

More from Geography

Canada Cuts Red Tape With Single Ethics Review For Trials
Jun 02 2025
A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.
Nancy Test Circulable Section Geography
May 01 2025
• By Brian Bossetta
This is a short description
Diversity Action Plans: What To Submit And When
Apr 24 2025
• By Nielsen Hobbs
With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.